AU2002259005A1 - Compositions and methods for inducing cancer cell death - Google Patents

Compositions and methods for inducing cancer cell death

Info

Publication number: AU2002259005A1
Authority: AU; Australia
Prior art keywords: compositions; methods; cancer cell; cell death; inducing cancer
Prior art date: 2001-04-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002259005A

Inventor

Steven F. Dowdy

Sergei A. Ezhevsky

Jay S. Wadia

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Washington University in St Louis WUSTL

Original Assignee

University of Washington

Washington University in St Louis WUSTL

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-24

Filing date

2002-04-24

Publication date

2002-11-05

2002-04-24 Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington

2002-11-05 Publication of AU2002259005A1 publication Critical patent/AU2002259005A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AU2002259005A 2001-04-24 2002-04-24 Compositions and methods for inducing cancer cell death Abandoned AU2002259005A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US28609901P	2001-04-24	2001-04-24
US60/286,099		2001-04-24
PCT/US2002/013092 WO2002085305A2 (en)	2001-04-24	2002-04-24	Compositions and methods for inducing cancer cell death

Publications (1)

Publication Number	Publication Date
AU2002259005A1 true AU2002259005A1 (en)	2002-11-05

Family

ID=23097063

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002259005A Abandoned AU2002259005A1 (en)	2001-04-24	2002-04-24	Compositions and methods for inducing cancer cell death

Country Status (2)

Country	Link
AU (1)	AU2002259005A1 (en)
WO (1)	WO2002085305A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1377667T3 (en) *	2001-03-30	2009-03-30	Leadd Bv	Fusion proteins for specific treatment of cancer and autoimmune diseases
AU2004316996A1 (en) *	2003-06-20	2005-09-15	The Regents Of The University Of California	Polypeptide transduction and fusogenic peptides
JP2008539209A (en) *	2005-04-26	2008-11-13	カリヨン−シーティーティーリミテッド	Diagnostic and therapeutic agents
CN101081871A (en) *	2006-05-31	2007-12-05	华中科技大学	Protein transduction field 4-apopain fusion protein (PTD4-Apoptin) and preparation method and application thereof
CN101747437B (en) *	2008-12-10	2012-09-26	浙江日升昌药业有限公司	Apoptin-EC-SOD carboxyl terminal protein transduction domain fusion protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1188832A1 (en) *	2000-09-08	2002-03-20	Leadd B.V.	A delivery method for the tumor specific apoptosis inducing activity of apoptin
DK0830604T3 (en) *	1995-06-07	2003-09-29	Leadd Bv	Applications of apoptin

2002
- 2002-04-24 AU AU2002259005A patent/AU2002259005A1/en not_active Abandoned
- 2002-04-24 WO PCT/US2002/013092 patent/WO2002085305A2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2002085305A3 (en)	2003-12-18
WO2002085305A2 (en)	2002-10-31

Similar Documents

Publication	Publication Date	Title
WO2003073826A8 (en)	2005-04-28	Novel compositions and methods for cancer
EP1578396A3 (en)	2005-09-29	Methods and compositions concerning poxviruses and cancer
EP2671581B8 (en)	2019-11-13	Compositions and methods for treating cancer
AU2002357119A1 (en)	2003-06-30	Mitocidal compositions and methods
AU2003230750A1 (en)	2003-10-13	Compositions and methods for treating cancer
AU2002346432A1 (en)	2003-07-24	Compositions and methods for increasing cell proliferation comprising a flavonoid
AU2001280968A1 (en)	2002-02-13	Compositions and methods for directed gene assembly
AU2003262833A1 (en)	2004-03-11	Fluorescent glycosides and methods for their use
AU2003239129A1 (en)	2003-10-27	Methods and compositions for dna manipulation
AU2002247304A1 (en)	2002-09-19	Anti-neovasculature preparations for cancer
AU2002361623A1 (en)	2003-05-19	Methods and compositions for chromatography
AU2003225535A1 (en)	2003-09-02	Methods and compositions for treating cancer
AU2002364708A1 (en)	2003-06-10	Novel compositions and methods for cancer
AU2001245987A1 (en)	2001-10-08	Compositions and methods for gene therapy
EP1509539A4 (en)	2006-05-17	Novel compositions and methods for cancer
AU2002357748A1 (en)	2003-06-10	Osteopontin-related compositions and methods
EP1469769A4 (en)	2008-06-18	Novel compositions and methods for cancer
AU2002341749A1 (en)	2003-04-01	Methods and compositions for inhibiting the proliferation of prostate cancer cells
AU2002258740A1 (en)	2002-10-21	Methods and compounds for decreasing cell toxicity or death
AU2001283226A1 (en)	2003-02-24	Methods and compositions for inhibiting rad51
AU2002337943A1 (en)	2003-05-06	Novel compositions and methods for cancer
AU2002366809A1 (en)	2003-07-09	Syn3 compositions and methods
EP1469870A4 (en)	2005-11-02	Novel compositions and methods for cancer
AU2002259005A1 (en)	2002-11-05	Compositions and methods for inducing cancer cell death
AU2002337713A1 (en)	2003-04-07	Pharmaceutical compositions and methods for treating cancer

Legal Events

Date	Code	Title	Description
2004-02-19	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase